A COMPARISON OF EFFECTIVE TREATMENT OF 5%TOPICAL MINOXIDIL VERSUS 5% TOPICAL MINOXIDIL AND 0.25% FINASTERIDE FOR HAIR LOSS IN MEN

A RANDOMIZED, COMPARATIVE, OPEN, INTERVENTIONAL STUDY OF EFFICACY OF 5%TOPICAL MINOXIDIL VERSUS COMBINATION OF 5% TOPICAL MINOXIDIL AND 0.25% TOPICAL FINASTERIDE IN ANDROGENIC ALOPECIA. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/095857

Enrollment

Registered

2025-10-09

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

Intervention1: 5% Minoxidil: Male patients aged 25-45 years diagnosed with Androgenic Alopecia will be divided randomly into 2 groups. Group A will be given topical 5% Minoxidil twice daily and Group

Eligibility

Inclusion criteria

Inclusion criteria: Men with the age group between 25-45 years. Men with Androgenic Alopecia. Patients who have given their consent.

Exclusion criteria

Exclusion criteria: Men above 45 years of age with androgenic alopecia. Men with any chronic medical disorders and those on medications within the last 6 months. Men with other dermatological disorders of the scalp. Men who have not given consent.

Design outcomes

Primary

Measure	Time frame
Compare the efficacy of 5% topical minoxidil versus combination of 5% topical minoxidil and 0.25% topical finasteride in male patients with androgenic alopecia. It will be assessed through global photography. Primary outcome will be change in hair density and hair diameterTimepoint: 12 weeks	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDR Sridevi S A

ACS Medical college and Hospital

sridevidakshya@gmail.com9884477103

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026